Source: US National Institute of Justice (video statements)
This presentation is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
This webinar is part of the Molecular Autopsy Implementation Panel, hosted by the NIJ Forensic Technology Center of Excellence on September 26, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
In her State of the European Union speech (SOTEU 2025), President Ursula von Der Leyen addresses the housing crisis and she is putting affordable housing as a clear goal for Europe’s future.
This year, the European Commission will present the first European Affordable Housing Plan that will make homes more affordable, sustainable, and accessible across Europe. From revising state aid rules to supporting student housing and tackling short-term rentals, this plan aims to turn housing into a social right for all.
Source: US National Institute of Justice (video statements)
With the passage of the 2018 Agricultural Improvement Act (Farm Bill), forensic laboratories have been tasked with differentiating seized cannabis samples as either hemp or marijuana. The new legislation declassified hemp as a Schedule 1 drug substance and defined it as cannabis containing 0.3 % or less of decarboxylated-Δ9-THC (total Δ9-THC). The National Institute of Standards and Technology (NIST) has been working to help forensic laboratories with these challenging measurements through the development of extraction protocols and analytical methods. This webinar provides a summary of the method development studies and screening of cannabis plant and cannabis-derived finished products commercially available.
This webinar was hosted by the NIJ Forensic Technology Center of Excellence on June 27, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
Source: US National Institute of Justice (video statements)
The reauthorization of hemp due to the Agriculture Improvement Act of 2018 (Farm Bill) has caused a proliferation of products that contain cannabidiol (CBD). While CBD is considered ‘legal’ under the Farm-Bill, there are concerns that the labeling of CBD products is inaccurate, and that the products may contain other cannabinoids, including Δ9-tetrahydrocannabinol (THC), the main psychoactive compound in marijuana. Other concerns include the potential for conversion of CBD to other cannabinoids during analysis of biological matrices and in acidic foods and beverages. Incorrect labeling and/or conversion can lead to false positives during analysis and unintentional ingestion of THC, which may result in impairment and/or positive drug tests. In this presentation, Dr. Lawrance Mullen provides a landscape of the public health impact of CBD, the importance of proper analytical technique to prevent false positive drug tests, and the results of a study conducted on acidic foods and beverages.
This webinar was hosted by the NIJ Forensic Technology Center of Excellence on May 18, 2023.
(Opinions or points of view expressed represent the speaker and do not necessarily represent the official position or policies of the U.S. Department of Justice. Any product or manufacturer discussed is presented for informational purposes only and do not constitute product approval or endorsement by the U.S. Department of Justice.)
